Headquartered in San Diego, CA Fiscal year ends December NASDAQ: TNDM tandemdiabetes.com
Tandem Diabetes Care is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems designed to reduce the burden of diabetes management. The company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both utilizing Control-IQ+ advanced hybrid closed-loop technology. Tandem sells its products in the United States and internationally, with revenue derived from both pump hardware sales and recurring supplies. The company is expanding its reimbursement model in the U.S. through a pay-as-you-go pharmacy channel and is broadening its international direct operations. Its products are compatible with continuous glucose monitors from Dexcom and Abbott, and the company continues to pursue regulatory clearances to expand indications and device capabilities, including tubeless pump functionality. Updated
Pre-Market Stock Futures: The futures are trading lower after what started as a bounce-back Monday turned into a reversal Monday, as the AI/Datacenter rotation trade continues to gather steam during the last…
Wednesday’s top analyst upgrades and downgrades included Amgen, Bed Bath & Beyond, Carlyle, Coinbase Global, Enovix, GoodRx, Healthcare Realty Trust, Micron Technology, NRG Energy, Nutrien, Nvidia, Roku, Take-Two Interactive Software and Tellurian.
Friday's top analyst upgrades and downgrades included AbbVie, Amazon.com, APA, CF Industries, Costco Wholesale, eBay, Etsy, GoDaddy, Intercontinental Exchange, Lululemon Athletica, Match, MetLife, Twilio, Uber Technologies, Virgin Galactic and Wayfair.
The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts. Here are seven that could be winners…
Tuesday's top analyst upgrades, downgrades and initiations included Aurora Cannabis, Biogen, EverQuote, Micron Technology, Nio, Nvidia, Palo Alto Networks, Tandem Diabetes Care, Tesla and Wix.com.
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and Zynga.
Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, American Water Works, Caterpillar, Cisco Systems, Comcast, Gap, Lululemon Athletica, Nike, Slack, Stitch Fix, Tesla and Under Armour.
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
Friday's top analyst upgrades, downgrades and initiations included Ambarella, Apple, Comcast, Costco, CSX, Domino's, Dish Network, Etsy, HP, 3M, Nike, PepsiCo and Snap.
Tandem Diabetes Care is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems designed to reduce the burden of diabetes management.
The Wall Street consensus 12-month price target for TNDM is $28.35.
